商务合作
动脉网APP
可切换为仅中文
New Delhi:
新德里:
Aurobindo Pharma
Aurobindo制药公司
will commence supplies to Europe from its China facility from April onwards, according to Chief Financial Officer Santhanam Subramanian. The Hyderabad-based drug maker commenced operations at the facility in the last week of November 2024 and is now ramping up the production.
首席财务官桑塔纳姆·苏布拉曼尼亚(SanthanamSubramanian)表示,该公司将从4月起开始从其中国工厂向欧洲供货。这家总部位于海得拉巴的制药商于2024年11月的最后一周开始在该工厂运营,目前正在扩大生产。
Trump-Modi Meet
特朗普·莫迪会面
The mega MIGA, MAGA plans of India's Modi and US' Trump
印度莫迪和美国特朗普的大型多边投资担保机构、多边投资担保机构计划
Trump says India has more tariffs than others
特朗普表示,印度的关税比其他国家高
Trump's 'golden rule' for imposing reciprocal tariffs
特朗普实施互惠关税的“黄金法则”
'The
China plant
中国工厂
will start billing sometime in the month of April, mainly to the European markets,' Subramanian told analysts in a call.
Subramanian在电话中告诉分析师,该公司将在4月份的某个时候开始计费,主要针对欧洲市场。
The company has received European
该公司已收到欧洲
regulatory approvals
监管机构批准
and can initiate product supply to the market, he added.
他补充道,它可以启动产品向市场的供应。
'We are in the process of getting it (in China) and after that there may be an inspection for the US (market) also,' Subramanian said.
Subramanian说,我们正在(在中国)获得它,之后可能还会对美国(市场)进行检查。
The company expects good traction coming out of the China plant over the next 2-3 years, he noted.
他指出,该公司预计在未来2-3年内,中国工厂将获得良好的牵引力。
Artificial Intelligence(AI)
人工智能(AI)
Java Programming with ChatGPT: Learn using Generative AI
使用ChatGPT进行Java编程:使用生成AI学习
By - Metla Sudha Sekhar, IT Specialist and Developer
作者:IT专家和开发人员Metla Sudha Sekhar
View Program
查看程序
Artificial Intelligence(AI)
人工智能(AI)
Basics of Generative AI: Unveiling Tomorrows Innovations
生成人工智能的基础:揭开明天的创新
By - Metla Sudha Sekhar, IT Specialist and Developer
作者:IT专家和开发人员Metla Sudha Sekhar
View Program
查看程序
Artificial Intelligence(AI)
人工智能(AI)
Generative AI for Dynamic Java Web Applications with ChatGPT
使用ChatGPT为动态Java Web应用程序生成AI
By - Metla Sudha Sekhar, IT Specialist and Developer
作者:IT专家和开发人员Metla Sudha Sekhar
View Program
查看程序
Artificial Intelligence(AI)
人工智能(AI)
Mastering C++ Fundamentals with Generative AI: A Hands-On
使用生成人工智能掌握C++基础知识:实践
By - Metla Sudha Sekhar, IT Specialist and Developer
作者:IT专家和开发人员Metla Sudha Sekhar
View Program
查看程序
Artificial Intelligence(AI)
人工智能(AI)
Master in Python Language Quickly Using the ChatGPT Open AI
使用ChatGPT Open AI快速掌握Python语言
By - Metla Sudha Sekhar, IT Specialist and Developer
作者:IT专家和开发人员Metla Sudha Sekhar
View Program
查看程序
Office Productivity
办公室生产力
Zero to Hero in Microsoft Excel: Complete Excel guide 2024
Microsoft Excel中的Zero to Hero:完成Excel指南2024
By - Metla Sudha Sekhar, IT Specialist and Developer
作者:IT专家和开发人员Metla Sudha Sekhar
View Program
查看程序
Marketing
市场营销
Performance Marketing for eCommerce Brands
电子商务品牌的绩效营销
By - Zafer Mukeri, Founder- Inara Marketers
作者:伊纳拉营销公司创始人扎弗·穆克里
View Program
查看程序
Finance
财务
A2Z Of Money
A2Z货币
By - elearnmarkets, Financial Education by StockEdge
电子学习市场,StockEdge金融教育
View Program
查看程序
Astrology
占星术
Vastu Shastra Course
反对沙斯特拉球场
By - Sachenkumar Rai, Vastu Shashtri
作者:Sachenkumar Rai,Vastu Shashtri
View Program
查看程序
Marketing
市场营销
Modern Marketing Masterclass by Seth Godin
塞思·戈丁的现代营销大师课
By - Seth Godin, Former dot com Business Executive and Best Selling Author
作者-赛斯·戈丁,前网络公司业务主管兼畅销书作家
View Program
查看程序
Data Science
数据科学
SQL for Data Science along with Data Analytics and Data Visualization
用于数据科学以及数据分析和数据可视化的SQL
By - Metla Sudha Sekhar, IT Specialist and Developer
作者:IT专家和开发人员Metla Sudha Sekhar
View Program
查看程序
Strategy
战略
Succession Planning Masterclass
继任计划大师班
By - Nigel Penny, Global Strategy Advisor: NSP Strategy Facilitation Ltd.
作者:奈杰尔·彭妮,全球战略顾问:NSP战略促进有限公司。
View Program
查看程序
Web Development
Web开发
A Comprehensive ASP.NET Core MVC 6 Project Guide for 2024
一个全面的ASP。2024年NET Core MVC 6项目指南
By - Metla Sudha Sekhar, IT Specialist and Developer
作者:IT专家和开发人员Metla Sudha Sekhar
View Program
查看程序
Artificial Intelligence(AI)
人工智能(AI)
AI and Analytics based Business Strategy
基于人工智能和分析的业务战略
By - Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI
作者:Tanusree De,埃森哲技术主管,值得信赖的人工智能卓越中心:ATCI
View Program
查看程序
Marketing
市场营销
Digital Marketing Masterclass by Pam Moore
Pam Moore数字营销大师班
By - Pam Moore, Digital Transformation and Social Media Expert
作者:Pam Moore,数字转型和社交媒体专家
View Program
查看程序
Office Productivity
办公室生产力
Mastering Microsoft Office: Word, Excel, PowerPoint, and 365
掌握Microsoft Office:Word、Excel、PowerPoint和365
By - Metla Sudha Sekhar, IT Specialist and Developer
作者:IT专家和开发人员Metla Sudha Sekhar
View Program
查看程序
Marketing
市场营销
Digital marketing - Wordpress Website Development
数字营销-Wordpress网站开发
By - Shraddha Somani, Digital Marketing Trainer, Consultant, Strategiest and Subject Matter expert
作者:Shraddha Somani,数字营销培训师、顾问、战略专家和主题专家
View Program
查看程序
Web Development
Web开发
Mastering Full Stack Development: From Frontend to Backend Excellence
掌握全栈开发:从前端到后端的卓越
By - Metla Sudha Sekhar, IT Specialist and Developer
作者:IT专家和开发人员Metla Sudha Sekhar
View Program
查看程序
Finance
财务
Financial Literacy i.e Lets Crack the Billionaire Code
金融素养,即破解亿万富翁密码
By - CA Rahul Gupta, CA with 10+ years of experience and Accounting Educator
作者:CA Rahul Gupta,CA,拥有10多年经验和会计教育工作者
View Program
查看程序
Artificial Intelligence(AI)
人工智能(AI)
AI-Powered Python Mastery with Tabnine: Boost Your Coding Skills
使用Tabnine掌握人工智能支持的Python:提高您的编码技能
By - Metla Sudha Sekhar, IT Specialist and Developer
作者:IT专家和开发人员Metla Sudha Sekhar
View Program
查看程序
When asked about revenue projections, Subramanian stated: 'This being the first year, we may not like to, but certainly I see a significant revenue coming up in two to three years' time.'
当被问及收入预测时,Subramanian表示:“这是第一年,我们可能不喜欢,但我肯定会在两三年后看到可观的收入。”
On a query regarding the company's
关于公司
biologics business
生物制品业务
,
,
Aurobindo Pharma
Aurobindo制药公司
Director and CEO of Biologics,
生物制品董事兼首席执行官,
Vaccines
疫苗
, and
,以及
Peptides
肽
Satakarni
Satacars
Makkapati
Makkapati
said 2028-30 will be the inflection point for the segment.
预计2028-30年将是该细分市场的拐点。
'We have three products which are approved, two with a positive opinion in Europe, one in the UK, and we are expecting one more this year with Denosumab, Omalizumab, and one more in the next year, we expect at least seven products to be commercialised fully by the year 2027(28),' he said.
他说:“我们有三种产品获得批准,其中两种在欧洲获得了积极的评价,一种在英国,我们预计今年还会有一种使用Denosumab、Omalizumab的产品,明年还会有一种。我们预计到2027年(28),至少有七种产品会完全商业化。”。
By 2028-30, the company expects to build a good revenue base, he added. 'So, we are enthusiastic about the progress that we are making and we are very sure footed in our investment and very prudent about the product choices we are making in the biosimilar segment,' Makkapati said.
他补充说,到2028-30年,该公司预计将建立一个良好的收入基础因此,我们对正在取得的进展充满热情,我们的投资非常稳健,对我们在生物仿制药领域的产品选择非常谨慎,”Makkapati说。
Aurobindo Pharma reported 10 per cent year-on-year dip in consolidated net profit at Rs 846 crore for the third quarter ended December 31, 2024. Its revenue from operations increased to Rs 7,979 crore in the quarter as compared to Rs 7,352 crore in the year-ago period.
Aurobindo Pharma报告称,截至2024年12月31日的第三季度,合并净利润同比下降10%,为8.46亿卢比。与去年同期的73.52亿卢比相比,该季度的运营收入增加至79.79亿卢比。
(You can now subscribe to our
(您现在可以订阅我们的
Economic Times WhatsApp channel
经济时报WhatsApp频道
)
)
(You can now subscribe to our
(您现在可以订阅我们的
Economic Times WhatsApp channel
经济时报WhatsApp频道
)
)